Mr Flannery, a Financial Review Rich Lister whose investment in Tritium dates back to 2017, said he was disappointed in the company’s performance and decision-making.
Mr Flannery’s 8 per cent stake in Tritium at listing in May 2021 was worth $US96 million. His current 5 per cent stake is valued at $US1.66m.
“They should have bitten the bullet and moved to the United States earlier and kept an R&D [research and development] centre in Brisbane,” he told The Australian…
Comments are closed